云南白药资产负债表
来源:动视网
责编:小OO
时间:2025-09-25 06:55:43
云南白药资产负债表
是惺惺相惜资产负债表2012-03-312011-12-312011-09-302011-06-30流动资产货币资金976,956,246.321,142,709,549.941,262,556,159.191,627,590,700.62交易性金融资产519,683.25519,683.2500应收票据1,817,957,627.31,914,223,8.731,578,573,862.831,245,352,651.25应收账款813,358,624.44413,371,2.745
导读是惺惺相惜资产负债表2012-03-312011-12-312011-09-302011-06-30流动资产货币资金976,956,246.321,142,709,549.941,262,556,159.191,627,590,700.62交易性金融资产519,683.25519,683.2500应收票据1,817,957,627.31,914,223,8.731,578,573,862.831,245,352,651.25应收账款813,358,624.44413,371,2.745
是惺惺相惜资产负债表 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 |
流动资产 | |
货币资金 | 976,956,246.32 | 1,142,709,549.94 | 1,262,556,159.19 | 1,627,590,700.62 |
交易性金融资产 | 519,683.25 | 519,683.25 | 0 | 0 |
应收票据 | 1,817,957,627.3 | 1,914,223,8.73 | 1,578,573,862.83 | 1,245,352,651.25 |
应收账款 | 813,358,624.44 | 413,371,2.7 | 450,513,214.5 | 631,850,741.51 |
预付账款 | 347,604,752.77 | 2,709,208.61 | 526,990,465.29 | 430,413,249.34 |
应收股利 | 0 | -- | 0 | 0 |
应收利息 | 4,809,682.46 | 5,170,032.46 | 4,177,277.73 | 5,565,694.39 |
其他应收款 | 105,109,122.31 | 75,243,942.78 | 121,434,287.3 | 94,587,959.3 |
存货 | 3,960,152,488.72 | 3,535,867,425.92 | 3,793,225,637 | 3,280,801,526.2 |
消耗性生物资产 | -- | -- | -- | -- |
待摊费用 | -- | -- | -- | -- |
一年内到期的非流动资产 | 0 | -- | 0 | 0 |
其他流动资产 | 0 | -- | 0 | 0 |
影响流动资产其他科目 | 0 | 0 | 0 | 0 |
流动资产合计 | 8,026,468,227.57 | 7,376,815,022.39 | 7,737,470,903.84 | 7,316,162,522.61 |
非流动资产 | |
可供出售金融资产 | 0 | -- | 0 | 0 |
持有至到期投资 | 0 | -- | 0 | 0 |
投资性房地产 | 0 | -- | 0 | 0 |
长期股权投资 | 29,932,807.06 | 30,154,371.07 | 30,3,327.12 | 30,651,212.54 |
长期应收款 | 0 | -- | 0 | 0 |
固定资产 | 1,022,847,849.42 | 1,033,185,052.11 | 224,084,742.76 | 227,240,162.42 |
工程物资 | 0 | -- | 0 | 0 |
在建工程 | 356,739,394.1 | 298,231,339.58 | 1,016,491,245.88 | 961,773,670.17 |
固定资产清理 | 0 | -- | 0 | 0 |
生产性生物资产 | 0 | -- | 0 | 0 |
油气资产 | 0 | -- | 0 | 0 |
无形资产 | 242,917,319.45 | 244,338,401.04 | 114,694,423.28 | 117,354,860.06 |
开发支出 | 0 | -- | 0 | 0 |
商誉 | 12,843,661.62 | 12,843,661.62 | 12,843,661.62 | 12,843,661.62 |
长期待摊费用 | 22,520,0.73 | 17,415,142 | 8,694,121.24 | 5,341,761.45 |
递延所得税资产 | 67,935,387.37 | 67,935,387.37 | 50,996,182.47 | 51,028,304.77 |
其他非流动资产 | 10,000,000 | 10,000,000 | 10,149,793.68 | 10,000,000 |
影响非流动资产其他科目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 1,765,736,483.75 | 1,714,103,354.79 | 1,468,343,498.05 | 1,416,233,633.03 |
资产总计 | 9,792,204,711.32 | 9,090,918,377.18 | 9,205,814,401. | 8,732,396,155. |
流动负债 | |
短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
交易性金融负债 | 0 | -- | 0 | 0 |
应付票据 | 575,5,327.59 | 507,401,715.05 | 423,522,126.11 | 373,200,971.67 |
应付账款 | 1,969,034,180. | 1,590,135,442.07 | 1,785,091,160.09 | 1,697,105,115.28 |
预收账款 | 346,813,542.36 | 343,814,603.11 | 414,900,060.04 | 417,156,930.97 |
应付职工薪酬 | 16,503,141.03 | 42,939,1.71 | 17,790,909.63 | 16,840,404. |
应交税费 | 110,091,154.65 | 79,070,505.32 | 137,517,707.02 | 141,860,569.94 |
应付利息 | 312,000 | 312,000 | 312,000 | 312,000 |
应付股利 | 843,994.42 | 843,994.42 | 843,994.42 | 70,270,2.32 |
其他应付款 | 723,453,7.62 | 767,152,757.06 | 1,022,882,151.28 | 905,201,024.65 |
预提费用 | -- | -- | -- | -- |
预计负债 | -- | -- | -- | -- |
递延收益-流动负债 | -- | -- | -- | -- |
一年内到期的非流动负债 | 0 | -- | 0 | 0 |
应付短期债券 | -- | -- | -- | -- |
其他流动负债 | 0 | -- | 0 | 0 |
影响流动负债其他科目 | 0 | -- | 0 | 0 |
流动负债合计 | 3,752,616,105.56 | 3,341,670,658.74 | 3,812,860,108.59 | 3,631,947,659.47 |
非流动负债 | |
长期借款 | 6,684,882.14 | 6,684,882.14 | 6,684,882.14 | 6,684,882.14 |
应付债券 | 0 | -- | 0 | 0 |
长期应付款 | 4,944,832.43 | 4,944,832.43 | 4,944,832.43 | 4,944,832.43 |
专项应付款 | 0 | -- | 0 | 0 |
递延所得税负债 | 0 | -- | 0 | 0 |
递延收益-非流动负债 | -- | -- | -- | -- |
其他非流动负债 | 182,163,835.09 | 182,336,113.15 | 177,2,286.95 | 179,773,520.99 |
影响非流动负债其他科目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 193,793,549.66 | 193,965,827.72 | 188,4,001.52 | 191,403,235.56 |
负债合计 | 3,946,409,655.22 | 3,535,636,486.46 | 4,001,754,110.11 | 3,823,350,5.03 |
所有者权益 | |
实收资本(或股本) | 694,266,479 | 694,266,479 | 694,266,479 | 694,266,479 |
资本公积金 | 1,250,599,188.94 | 1,250,599,188.94 | 1,250,670,854.23 | 1,250,670,854.23 |
盈余公积金 | 365,700,202.26 | 365,700,202.26 | 273,935,101.21 | 273,935,101.21 |
未分配利润 | 3,535,293,949.69 | 3,244,780,784.31 | 2,985,634,357.15 | 2,6,722,963.47 |
库存股 | 0 | -- | 0 | 0 |
外币报表折算差额 | -,763.79 | -,763.79 | -446,499.81 | -446,499.81 |
未确认的投资损失 | -- | -- | -- | -- |
少数股东权益 | -- | -- | -- | -- |
归属于母公司股东权益合计 | 5,845,795,056.1 | 5,555,281,0.72 | 5,204,060,291.78 | 4,908,148,8.1 |
影响所有者权益其他科目 | 0 | -- | 0 | 0 |
所有者权益合计 | 5,845,795,056.1 | 5,555,281,0.72 | 5,204,060,291.78 | 4,909,045,260.61 |
负债及所有者权益总计 | 9,792,204,711.32 | 9,090,918,377.18 | 9,205,814,401. | 8,732,396,155. |
利润分配表
报告期 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 |
一、营业总收入 | 2,802,117,505.57 | 11,312,322,432.03 | 7,741,652,400.02 | 5,073,819,986.19 |
营业收入 | 2,802,117,505.57 | 11,312,322,432.03 | 7,741,652,400.02 | 5,073,819,986.19 |
二、营业总成本 | 2,461,941,813.61 | 9,956,426,371.45 | 6,769,161,248.85 | 4,427,997,128.87 |
营业成本 | 2,008,579,045.26 | 7,921,808,228.14 | 5,339,3,353.17 | 3,456,570,239.61 |
营业税金及附加 | 11,668,561.28 | 61,101,634.8 | 31,905,309.04 | 19,167,982.1 |
销售费用 | 368,268,107.38 | 1,666,342,484.66 | 1,200,236,903.15 | 809,625,614.24 |
管理费用 | 74,859,7.56 | 317,805,508.35 | 200,957,817.84 | 138,359,134.59 |
财务费用 | -1,433,547.87 | -19,309,384.7 | -18,926,313.72 | -10,820,021.04 |
资产减值损失 | 0 | 8,677,900.2 | 15,094,179.37 | 15,094,179.37 |
三、其他经营收益 | 0 | 199,688.6 | -182,047.42 | -182,047.42 |
公允价值变动净收益 | 0 | -- | 0 | 0 |
投资净收益 | 1,278,435.99 | 16,825,709.87 | 9,638,191.93 | 9,722,305.78 |
联营、合营企业投资收益 | -- | -- | -- | -- |
汇兑净收益 | 0 | -- | 0 | 0 |
四、营业利润 | 341,454,127.95 | 1,372,721,770.45 | 982,129,343.1 | 655,545,163.1 |
营业外收入 | 4,205,481.3 | 38,884,562.51 | 28,032,249.39 | 4,122,215.98 |
营业外支出 | 394,020.61 | 4,638,600.18 | 3,002,3.06 | 862,591.71 |
非流动资产处置净损失 | 0 | -- | 0 | 0 |
五、利润总额 | 345,265,588. | 1,406,967,732.78 | 1,007,159,228.43 | 658,804,787.37 |
所得税 | 54,752,423.26 | 196,059,925.09 | 148,059,311.11 | 94,719,901.22 |
未确认的投资损失 | -- | -- | -- | -- |
六、净利润 | 290,513,165.38 | 1,210,907,807.69 | 859,099,917.32 | 5,084,886.15 |
少数股东损益 | 0 | -858.77 | 0 | -858.42 |
归属于母公司股东的净利润 | 290,513,165.38 | 1,210,908,666.46 | 859,099,917.32 | 5,085,744.57 |
七、每股收益 | |
基本每股收益 | 0.42 | 1.74 | 1.24 | 0.81 |
稀释每股收益 | 0.42 | 1.74 | 1.24 | 0.81 |
现金流量表
报告期 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 |
一、经营活动产生的现金流量 | |
销售商品、提供劳务收到的现金 | 2,937,773,527.27 | 11,434,0,277.24 | 8,101,406,294.84 | 5,375,486,858.41 |
收到的税费返还 | 0 | 82,379.63 | 82,379.63 | 0 |
收到其他与经营活动有关的现金 | 8,844,202.47 | 100,418,540.86 | 70,345,165.5 | 23,745,760.48 |
经营活动现金流入小计 | 2,946,617,729.74 | 11,534,565,197.73 | 8,171,833,839.97 | 5,399,232,618. |
购买商品、接受劳务支付的现金 | 2,292,396,827.87 | 9,196,279,479.4 | 6,521,221,011.74 | 4,186,883,268.82 |
支付给职工以及为职工支付的现金 | 120,325,208.14 | 366,921,371.81 | 202,925,032.38 | 126,234,350.66 |
支付的各项税费 | 154,691,748.02 | 829,580,823.6 | 507,787,123.76 | 338,355,220.37 |
支付其他与经营活动有关的现金 | 515,026,973.13 | 1,5,571,630.02 | 1,307,922,531.81 | 909,229,069.43 |
经营活动现金流出小计 | 3,082,440,757.16 | 11,982,353,304.83 | 8,539,855,699.69 | 5,560,701,909.28 |
经营活动产生的现金流量净额 | -135,823,027.42 | -447,788,107.1 | -368,021,859.72 | -161,469,290.39 |
二、投资活动产生的现金流量 | |
收回投资收到的现金 | 0 | 106,375,000 | 204,131,6.28 | 104,131,6.28 |
取得投资收益收到的现金 | 1,500,000 | 9,100,245.56 | 10,297,242.29 | 10,118,310.72 |
处置固定资产、无形资产和其他长期 资产收回的现金净额 | 12,949.96 | 19,265,836.31 | 406,836.45 | 202,836.45 |
处置子公司及其他营业单位收到的现金净额 | 0 | -- | 0 | 0 |
收到其他与投资活动有关的现金 | 0 | 0 | 0 | 0 |
投资活动现金流入小计 | 1,512,949.96 | 134,741,081.87 | 214,835,768.02 | 114,452,836.45 |
购建固定资产、无形资产和其他长期资产支付的现金 | 31,312,026.16 | 365,443,613.27 | 306,787,371.95 | 218,212,874.87 |
投资支付的现金 | 0 | 100,968,027.45 | 200,968,027.45 | 100,000,000 |
取得子公司及其他营业单位支付的现金净额 | 0 | 2,900,870 | 1,160 | 0 |
支付其他与投资活动有关的现金 | 0 | 0 | 868.45 | 868.45 |
投资活动现金流出小计 | 31,312,026.16 | 469,312,510.72 | 507,757,427.85 | 318,213,743.32 |
投资活动产生的现金流量净额 | -29,799,076.2 | -334,571,428.85 | -292,921,659.83 | -203,760,906.87 |
三、筹资活动产生的现金流量 | |
吸收投资收到的现金 | 0 | -- | 0 | 0 |
子公司吸收少数股东投资收到的现金 | -- | -- | -- | -- |
取得借款收到的现金 | 0 | 10,000,000 | 0 | 0 |
收到其他与筹资活动有关的现金 | 0 | 0 | 0 | 0 |
发行债券收到的现金 | 0 | -- | 0 | 0 |
筹资活动现金流入小计 | 0 | 10,000,000 | 0 | 0 |
偿还债务支付的现金 | 0 | 10,000,000 | 0 | 0 |
分配股利、利润或偿付利息支付的现金 | -- | -- | -- | -- |
子公司支付给少数股东的股利 | -- | -- | -- | -- |
支付其他与筹资活动有关的现金 | 515,026,973.13 | 1,5,571,630.02 | 1,307,922,531.81 | 909,229,069.43 |
筹资活动现金流出小计 | 131,200 | 80,057,360.96 | 71,444,212.52 | 2,122,993.38 |
筹资活动产生的现金流量净额 | -131,200 | -70,057,360.96 | -71,444,212.52 | -2,122,993.38 |
四、现金及现金等价物净增加额 | |
汇率变动对现金的影响 | 0 | 165,832.5 | -16,723.09 | -16,723.09 |
现金及现金等价物净增加额 | -165,753,303.62 | -852,251,0.41 | -732,404,455.16 | -367,369,913.73 |
期初现金及现金等价物余额 | 1,142,709,549.94 | 1,994,960,614.35 | 1,994,960,614.35 | 1,994,960,614.35 |
期末现金及现金等价物余额 | 976,956,246.32 | 1,142,709,549.94 | 1,262,556,159.19 | 1,627,590,700.62 |
补充资料: | | | | |
云南白药资产负债表
是惺惺相惜资产负债表2012-03-312011-12-312011-09-302011-06-30流动资产货币资金976,956,246.321,142,709,549.941,262,556,159.191,627,590,700.62交易性金融资产519,683.25519,683.2500应收票据1,817,957,627.31,914,223,8.731,578,573,862.831,245,352,651.25应收账款813,358,624.44413,371,2.745